← Back to Search

Behavioural Intervention

Educational Intervention for Cancer Knowledge

N/A

Waitlist Available

Led By Stacy W Gray

Research Sponsored by City of Hope Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Diagnosis of lung, breast, colorectal, pancreatic, ovarian or prostate cancer

Eastern Cooperative Oncology Group (ECOG) performance status of 0-2

Must not have

Unable to provide informed consent

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 12-month period after results disclosure

Awards & highlights

No Placebo-Only Group

Summary

This trial studies a web-based cancer education tool called HOPE-Genomics. The tool provides patients with information about genomic testing and their own genomic test results. The goal is to improve patient's genomic knowledge and quality of patient-centered care.

Who is the study for?

This trial is for English-speaking adults over 18 with lung, breast, colorectal, pancreatic, ovarian or prostate cancer who are undergoing genomic sequencing. They must be enrolled in a specific review board and have a performance status indicating they can care for themselves.

What is being tested?

The trial tests the HOPE-Genomics web tool designed to educate cancer patients about their own genomic test results and general genomics knowledge. It aims to see if this improves understanding of personal testing outcomes and overall patient-centered care quality.

What are the potential side effects?

Since this study involves an educational intervention rather than medication or medical procedures, traditional physical side effects are not expected. Participants may experience information overload or stress related to learning about their genomic data.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with lung, breast, colorectal, pancreatic, ovarian, or prostate cancer.

Select...

I am able to care for myself and perform daily activities.

Select...

I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am unable to understand and give consent for treatment.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 12-month period after results disclosure

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 12-month period after results disclosure

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 12-month period after results disclosure for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Recall rates of personal genomic results

Secondary study objectives

Operationalization of contextual guideline concordant care

Other study objectives

General genomic knowledge

Genetically-guided care

HOPE-Genomics tool usage

+1 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups

Experimental Treatment

Active Control

Group I: Arm III (HOPE-Genomics, genomics test results)Experimental Treatment2 Interventions

Patients view HOPE-Genomics tool (containing educational content) over 15-20 minutes before their sequencing results are available. Patients also receive their genomics test results both from their clinician and from the HOPE-Genomics tool.

Group II: Arm II (genomics test results, HOPE-Genomics)Experimental Treatment3 Interventions

Patients receive their genomics test results both from their clinician and from the HOPE-Genomics tool. Patients then view HOPE-Genomics tool over 15-20 minutes after their results are available.

Group III: Arm I (usual care)Active Control2 Interventions

Patients receive education pamphlet about WES and have their genomics test results returned by their clinician in a typical manner.

0 / 4Eligibility criteria met